1. Zion Medical Announces Results of First Human Clinical Trial of HIV drug Gammora, Offering Potential Cure | Benzinga

    Zion Medical Announces Results of First Human Clinical Trial of HIV drug Gammora, Offering Potential Cure | Benzinga

     Zion Medical, an Israeli biotech company developing HIV and cancer treatments, has announced the results of the first clinical trial of HIV-drug Gammora, eliminating up to 99% of the HIV virus within four weeks of treatment.

     

    Investigational Medicinal Product (IMP) Gammora is a synthetic peptide compound derived from the HIV enzyme integrase, which is responsible for inserting the virus's genetic material into the DNA of the infected cell. Gammora stimulates the integration of multiple HIV DNA fragments into the host cell's genomic DNA, to an extent that triggers the self-destruction of the infected cell, called apoptosis. The peptide ...

    Read Full Article
  1. Categories

    1. News:

      News, Placeholder
  2. Quotes

    1. These first clinical results were beyond our expectations and promise hope in finding a cure for a disease that's been discovered over 35 years.
  3. Topics Mentioned